or Try an Advanced Search...

    Intravenous Infusion Stocks List

    Symbol Grade Name % Change
    REGN C Regeneron Pharmaceuticals, Inc. -0.03
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Angiogenesis Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cardiovascular Disease Cartilage Cholesterol Clinical Development Clinical Research Colorectal Cancer Dermatitis Disorders Human Monoclonal Antibodies Immune Diseases Immunology Infectious Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Intravenous Infusion stocks.

    Symbol Grade Name Weight
    IBB D iShares Nasdaq Biotechnology Index Fund 8.09
    IBBQ D Invesco Nasdaq Biotechnology ETF 8.07
    BBH D Market Vectors Biotech ETF 7.74
    BIB D ProShares Ultra Nasdaq Biotechnology 5.95
    PJP C PowerShares Dynamic Pharmaceuticals 5.72
    View all Intravenous Infusion ETFs...
    Compare ETFs
    Compare IBB to IBBQ Compare IBBQ to BIB Compare IBBQ to PJP

        Intravenous Infusion Stocks Recent News

        Date Stock Title
        Apr 19 REGN Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
        Apr 18 REGN Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
        Apr 17 REGN Why Investors Need to Take Advantage of These 2 Medical Stocks Now
        Apr 16 REGN Why Regeneron (REGN) Could Beat Earnings Estimates Again
        Apr 16 REGN Regeneron to 'vigorously defend' against DOJ on Eylea pricing complaint
        Apr 15 REGN UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation
        Apr 15 REGN Regeneron to defend against DOJ complaint on drug-price manipulation
        Apr 15 REGN Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
        Apr 15 REGN Regeneron commits $500M to new venture capital fund
        Apr 15 REGN Antitrust fervor is gripping Washington and Silicon Valley. But lawsuits have been declining.
        Apr 12 REGN Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
        Related Industries: Biotechnology
        Related Stock Lists: Angiogenesis Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cardiovascular Disease Cartilage Cholesterol Clinical Development Clinical Research Colorectal Cancer Dermatitis Disorders Human Monoclonal Antibodies Immune Diseases Immunology Infectious Diseases
        Intravenous Infusion

        Browse All Tags